|
|
|
Insider
Information: |
Ivers-Read Gillian C |
Relationship: |
See Remarks |
City: |
Boulder |
State: |
CO |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
293,612 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$4,404 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
293,612 |
|
|
Total
Value |
$4,404 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
27
|
Stock
price went up :
|
0
|
3
|
Stock
price went down : |
0
|
24
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
-1,222.7%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Welltek Incorporated |
WTKND |
EVP, Development Opera... |
2008-03-07 |
0 |
2004-12-09 |
0 |
Premium* |
|
Clovis Oncology, Inc. |
CLVS |
See Remarks |
2022-11-02 |
293,612 |
2011-11-21 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
117 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 4 of 5
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2018-01-16 |
4 |
AS |
$59.16 |
$177,480 |
D/D |
(3,000) |
183,571 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2018-02-15 |
4 |
AS |
$54.09 |
$162,270 |
D/D |
(3,000) |
180,571 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2019-03-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,375 |
190,257 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2017-12-20 |
4 |
D |
$63.80 |
$224,066 |
D/D |
(3,512) |
186,571 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2022-11-02 |
4 |
S |
$0.98 |
$3,618 |
D/D |
(3,681) |
293,612 |
0 |
% |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2021-08-03 |
4 |
S |
$4.82 |
$17,752 |
D/D |
(3,683) |
254,596 |
0 |
% |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2021-11-02 |
4 |
S |
$4.55 |
$16,817 |
D/D |
(3,696) |
259,658 |
0 |
% |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2022-05-02 |
4 |
S |
$1.97 |
$7,353 |
D/D |
(3,733) |
278,783 |
0 |
% |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2020-05-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,749 |
208,570 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2020-08-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,749 |
212,604 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2020-11-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,749 |
216,480 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2022-08-02 |
4 |
S |
$1.46 |
$5,555 |
D/D |
(3,802) |
286,090 |
0 |
% |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2021-05-04 |
4 |
S |
$5.54 |
$21,894 |
D/D |
(3,952) |
249,501 |
0 |
% |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2022-02-02 |
4 |
S |
$1.94 |
$8,616 |
D/D |
(4,442) |
263,974 |
0 |
% |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2022-06-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,062 |
283,845 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2022-09-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,063 |
291,153 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2011-11-21 |
4 |
B |
$13.00 |
$69,199 |
D/D |
5,323 |
218,583 |
2.74 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2020-02-04 |
4 |
S |
$8.41 |
$60,586 |
D/D |
(7,204) |
203,067 |
0 |
% |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2017-12-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,500 |
190,083 |
0 |
- |
|
WTKND |
Welltek Incorporated |
Vice President |
|
2004-12-14 |
4 |
OE |
$1.60 |
$12,240 |
D/D |
7,650 |
7,650 |
|
- |
|
WTKND |
Welltek Incorporated |
officerTitle |
|
2005-12-13 |
4 |
S |
$18.37 |
$140,787 |
D/D |
(7,650) |
0 |
|
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2021-05-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,374 |
251,684 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2021-08-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,374 |
256,630 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2021-11-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,374 |
261,699 |
0 |
- |
|
CLVS |
Clovis Oncology, Inc. |
See Remarks |
|
2022-05-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,374 |
280,845 |
0 |
- |
|
117 Records found
|
|
Page 4 of 5 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|